Compare LYTS & IRWD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | LYTS | IRWD |
|---|---|---|
| Founded | 1976 | 1998 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Building Products | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 699.9M | 741.8M |
| IPO Year | 1994 | 2009 |
| Metric | LYTS | IRWD |
|---|---|---|
| Price | $21.34 | $3.39 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 2 | 5 |
| Target Price | ★ $27.50 | $4.94 |
| AVG Volume (30 Days) | 132.3K | ★ 2.7M |
| Earning Date | 04-23-2026 | 05-26-2026 |
| Dividend Yield | ★ 0.96% | N/A |
| EPS Growth | N/A | ★ 1400.00 |
| EPS | ★ 0.43 | 0.15 |
| Revenue | ★ $573,377,000.00 | $298,276,000.00 |
| Revenue This Year | $8.01 | $41.42 |
| Revenue Next Year | $7.03 | $16.01 |
| P/E Ratio | $48.79 | ★ $22.53 |
| Revenue Growth | ★ 22.09 | 8.88 |
| 52 Week Low | $13.77 | $0.55 |
| 52 Week High | $24.75 | $5.78 |
| Indicator | LYTS | IRWD |
|---|---|---|
| Relative Strength Index (RSI) | 47.50 | 35.12 |
| Support Level | $17.84 | $3.15 |
| Resistance Level | $23.99 | $3.53 |
| Average True Range (ATR) | 0.93 | 0.37 |
| MACD | -0.22 | -0.16 |
| Stochastic Oscillator | 31.85 | 23.79 |
LSI Industries Inc provides corporate visual image solutions to the petroleum and convenience store industry. The company's operating segments include Lighting and Display Solutions. It generates maximum revenue from the Display solutions segment. Lighting Segment manufactures and markets outdoor and indoor lighting and lighting controls for the commercial, industrial, and multi-site retail markets, including the petroleum/convenience store, quick-service, and automotive markets. The Display Solutions Segment manufactures, sells, and installs exterior and interior visual image and display elements, including printed graphics, structural graphics, digital signage, menu board systems, display fixtures, refrigerated displays, and custom display elements.
Ironwood Pharmaceuticals Inc is a specialty and generic drug manufacturing company that operates a human therapeutics segment. The company is focused on advancing product opportunities in areas of large unmet need, including irritable bowel syndrome with constipation, chronic idiopathic constipation, hyperuricemia associated with uncontrolled gout, uncontrolled gastroesophageal reflux disease, and vascular and fibrotic diseases. The company considers collaborative licenses, commercial agreements, and acquisition investment to be potential components of its operational growth plan for expanding its research, development, manufacturing, and marketing capabilities.